The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

Abhishek, Abhishek; Tedeschi, Sara K.; Pascart, Tristan; Latourte, Augustin; Dalbeth, Nicola; Neogi, Tuhina; Fuller, Amy; Rosenthal, Ann; Becce, Fabio; Bardin, Thomas; Ea, Hang Korng; Filippou, Georgios; Fitzgerald, John; Iagnocco, Annamaria; Lioté, Frédéric; McCarthy, Geraldine M.; Ramonda, Roberta; Richette, Pascal; Sivera, Francisca; Andres, Mariano; Cipolletta, Edoardo; Doherty, Michael; Pascual, Eliseo; Perez-Ruiz, Fernando; So, Alexander; Jansen, Tim L; Kohler, Minna J.; Stamp, Lisa K.; Yinh, Janeth; Adinolfi, Antonella; Arad, Uri; Aung, Thanda; Benillouche, Eva; Bortoluzzi, Alessandra; Dau, Jonathan; Maningding, Ernest; Fang, Meika; Figus, Fabiana; Filippucci, Emilio; Haslett, Janine; Janssen, Matthijs; Kaldas, Marian; Kimoto, Maryann; Leamy, Kelly; Navarro, Geraldine M.; Sarzi-Puttini, Piercarlo; Scirè, Carlo; Silvagni, Ettore; Sirotti, Silvia; Stack, John; Truong, Linh; Xie, Chen; Yokose, Chio; Hendry, Alison; Terkeltaub, Robert; Taylor, William J.; Choi, Hyon K.

doi:10.1002/art.42619

All Outputs (4)

Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases (2024)
Journal Article
Fuller, A., Hancox, J., Williams, H. C., Card, T., Taal, M. W., Aithal, G. P., …Abhishek, A. (in press). Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases. Rheumatology, Article keae175. https://doi.org/10.1093/rheumatology/keae175

Objective To explore the acceptability of an individualised risk-stratified approach to monitoring for target-organ toxicity in adult patients with immune-mediated inflammatory diseases established on immune-suppressing treatment(s). Methods Adu... Read More about Patient and health professional views on risk-stratified monitoring of immune-suppressing treatment in adults with inflammatory diseases.

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease (2023)
Journal Article
Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., …Choi, H. K. (2023). The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis and Rheumatology, 75(10), 1703-1713. https://doi.org/10.1002/art.42619

Objective Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have develo... Read More about The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease (2023)
Journal Article
Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., …Choi, H. K. (2023). The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease. Annals of the Rheumatic Diseases, 82(10), 1248-1257. https://doi.org/10.1136/ard-2023-224575

Objective Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have develop... Read More about The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease.

The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease (2023)
Journal Article
Abhishek, A., Tedeschi, S. K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., …Choi, H. K. (2023). The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis and Rheumatology, 75(10), 1703-1713. https://doi.org/10.1002/art.42619

Objective Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) and EULAR have deve... Read More about The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease.